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Chelating Agents in Biological Systems
by Jack Schubert*
Chelation enables metals to be transported to or from vulnerable target sites, and to hinder or
facilitate their carcinogenic potential. In the reverse sense, metals are capable of ligand
scavenging via complexation or mixed complex formation-the latter being the result of
interaction with binary complexes. Consequently, metal complexes can be utilized for the
transport ofselected organic chemotherapeutic drugs to target organs, or for the decorporation
of those toxic organic compounds which are able, before or after metabolic activation, of
reacting with metals or 1:1 metal complexes. It is emphasizedthatthe degreetowhich metal ions
interact in vivo should employ the conditional constants which take into account competition
fromotherions,especiallyCa2+,H+,andOH-.Thegenotoxicconsequencesofthevariouschemical
factors involved in chelation, along with examples: kinetics, stabilization of oxidation states,
lipophilicity, and mixed ligand formation, are discussed.
Introduction
The transition metal ions inevitably exist as
metal complexes in biological systems by interac-
tion with the numerous molecules possessing group-
ings capable of complexation or chelation. Hence
we find essential metals such as Cu, Zn, Cr, Fe,
Mn, and Co existing as binary and ternary chelates
of amino acids, carboxylic acids, and proteins.
Without such interactions, life could not exist or be
maintained, or, as earlier expressed, "Life could
not exist or even come into being without the
mediating action ofmetals" (1). Wood (2) made the
cogent point when he wrote: ". . . metals are
involved in every aspect of biosynthesis, biode-
gradation, and in the assembly of macromolecular
structure. If you think that biochemistry is the
organic chemistry of living systems, then you are
misled: biochemistry is the coordination chemistry
of living systems." Certainly not all biochemical
reactions involve metal compounds. On the other
hand metals are involved in such a large number of
essential biological reactions that life as we know it
could not exist without coordination compounds.
The carcinogenic metals all have the ability-via
complexation or ternary complex formation-to
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interact with DNA and other nuclear constituents
or to alter such cellular properties as membrane
integrity. Chelationphenomenaenable metals to be
transported to or away from vulnerable target
sites, and to facilitate or hinder those intracellular
interactions which may ultimately lead to cancer.
In order to appreciate and apply the dual nature of
metalchelationincarcinogenesis, bothinitsinduction
and therapy, I shall review selected aspects ofthe
chemistry ofmetal ions, chelate formation, and the
stability of metal chelates. A more comprehensive
review of the chemistry of carcinogenic metals is
given elsewhere by Martell (3). These chemical
propertiesandresultingspeciationallhaveabearing
on the ability of a metal ion to interact with target
molecules. For example, while Cr(VI) as chromate,
CrO42-, enters cells, the ultimate mutagen or car-
cinogen from the chemical standpoint can only be
Cr(III) which is the state which chelates with
biological molecules as reference to the Sillen-
Martell tables reveals (4). In fact, Cr(III) is not
carcinogenic because it cannot penetrate cell mem-
branes, but Cr(VI) is reduced to Cr(III) within the
cell. On the other hand, chelation with exogenous
chelating agents can reduce or prevent its
mutagenicity (5). Similarly, results onthe antitumor
activity ofacid ruthenium amine complexes suggest
that reduction to Ru(II) occurs in vivo prior to
metal coordination to nucleic acids (6).
227I willemphasize the ability ofchelantsto combine
with and to transport metal ions-a process of
metal scavenging. This property, especially when
water-soluble, nonmetabolizable, and exeretable
chelates are formed, is widely applied for the
decorporation of toxic metals, both stable and
radioactive. A potentially useful "reverse" prop-
erty is ligand scavenging in which the goal is to
accelerate the excretion oftoxic organic substances
containing groupings capable of binding to a non-
toxic metal prior to or after metabolic activation.
Binary complexes may also combine with an addi-
tional ligand forming a mixed or ternary complex
(7). This latter property appears to be the mecha-
nism by which catecholamines (8, 9) are trans-
ported as well as nucleotides (10) and oxygen. In
this connection, therefore, it would appear that
metal complexes could transport organic chem-
otherapeutic drugs to target organs or remove
excessive levels of the drugs.
Chelate Formation and In Vivo
Stability
In biological systems important factors in the
actions ofmetal chelates include: (1) intrinsic stabil-
ity; (2) chelant-metal ratios; (3) stability as a
function of pH; (4) competition from other metals
and ligands, both endogenous and exogenous; (5)
overall charge and lipophilicity; and (6) rates of
hydrolysis and chelate formation. An excellent
review of the chemistry of chelation and factors
governing stability is provided by Mellor (11).
Chelating molecules possess at least two func-
tional groups containing donor atoms capable of
combining with the metal ion and so situated that a
ring is formed with the metal ion. Since most
chelants contain protons, these compete with the
metal ion for the chelant:
M + HnL = ML + nH+ (1)
where L represents the ligand and M the metal ion.
Generally we will focus on the binary 1:1 chelates
and occasionally on 1:2 chelates, i.e., ML2. The
fraction of the metal present as a chelate, ML,
derives from mass action:
ML/M = K/L) (2)
The equation shows that the fraction ofM in chelate
form, (ML)/[(M) + (ML)], is enhanced either by
increasing the concentration of the ligand, or by a
ligand produeing a higher formation constant, Kf.
Ligand concentrations, whether endogenous or ex-
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ogenous, do not or cannot be varied greatly, e.g.,
most chelants such as EDTA or diethylenetri-
aminepentaacetic acid (DPTA) used for therapy of
metal poisoning, become toxic above peak plasma
levels of10-3-104M. However, the values ofKfmay
range from 100to > 1030. Obviously, inthe choice of
chelants for biological use, the Kf values offer
greater flexibility for the scavenging and release of
bound metals or ligands.
When exogenous chelating agents are employed
in biological systems, the stability of the binary
complex as expressed by simple mass action does
not necessarily reflect actual in vivo behavior. For
example, in invivo systems, Hg(II) is not bound by
EDTA, despite the fact that the Kfof HgEDTA is
very high,A028. However, when competition from
some of the common ligands in the plasma is
considered, namely OH- and serum albumin for Hg
and H+ and Ca2' for EDTA, we find that there is
practically no net binding by EDTA for the mercu-
ry. When calculations commonly employed in ana-
lytical and coordination chemistry are adapted to
biological systems (12-14), they give the "condi-
tional constant" which provides a more direct
measure of metal chelate stability under biological
conditions.
One example (12) of the usefulness of the condi-
tional constant is the following: Fe(III)EDTA is
about 106 times stronger then Cu(II)EDTA in
conventional terms. Yet at pH 7, the Cu(II)EDTA
chelate is more than 102 times stronger than
Fe(III)EDTA (Fig. 1). This result, for example,
has a bearing on the ease of dissociation in vivo of
these chelates since they could result in the release
offree toxic metal ions in vulnerable tissue or cells.
Rate Effects
The rates at which chelate or complex ion forma-
tion take place have important biological conse-
quences, as, for example, in the manifestation or
reversal ofmetal ion mutagenicity in microbial test
systems (5). The rapid or labile reactions are
usually completed by the time of mixing while the
inert or robust systems may take minutes to days.
While most metal chelates, at least ofthe divalent
transition metals, Co, Cd, Mn, Zn, and Cu are
labile, those involving Cr(III), Fe(III), Co(III),
Mo(III), W(III), Mn(IV), Ru(II), Ni(II), and Pt(IV),
are often inert (11). Outer orbital complexes(sp2d3)
are usually labile and innerorbital (d2sp3) complexes
are either labile or inert, the former when at least
one d orbital is vacant, otherwise they are inert.
Hydrolyzable, polyvalent cations such as those of
Cr, V, Ti, Zr, and Pu, undergo a complicated series
of reactions with water and hydroxide ions, even-
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FIGURE 1. Variation of the log of the effe
constants with pH for the chelates of I
Cu(II)EDTA. The calculations included
Ca++, OH-, and H+. The curves are tal
published elsewhere (12).
tually leading toinorganic polymers. I
ions, such as Cr2O72- which cannot e:
pH > 5 will begin to change when sir
in water. Thus, Cr2072- becomes chr(
and HCrO4 . In fact, the genotoxicitn
measured in the rec-assay, decrease
after solution in water with half-life
The biological consequences of sloi
mean that different investigatorE
apparently confficting results, depe
time elapsed between the preparati(
tion and the biological testing.
Mixed (Ternary) Comple.
In biological systems metal ions u;
with two different ligands. For exan
ing of copper in serum by the norm
amino acids is greater than expect
individual binding properties. It ti
mixed complexes are fonned in whic
is bound simultaneously to two di
acids. Thebiological significance ofmi
isbecoming more and more recognize
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in the excellent review by Martin and Scharff(15).
Perrin (16) employed a simulated plasma solution
containing 22 amino acids and, by means of a
computer program, showed that at pH 7.4 most of
the copper was present as a mixed complex of
Cu-histidine-cysteine, and that an appreciable frac-
tion of zinc was found as a mixed complex of
Zn-cysteine-histidine (Fig. 2).
In the presence of two chelants, the metal ion
may formn two independent binary complexes:
L + A +2M = ML + MA (3)
Frequently the number ofdonoratoms orgroups in
a multidentate ligand is less than the coordination
number of the metal ion. This permits another
ligand to occupy these sites which would otherwise
contain solvent molecules. Formation ofthe mixed
complex usually occurs stepwise as follows:
L + A + M = L + A = MLA (4)
I I where ligand L has ahigherdenticitythanA, which
8 10 is usually bidentate. However, both ML and MA
are present to some extent, the relative fractions of
eachwould depend onIdnetics and relative stabilities.
etive (conditional) Large, highly charged anions such as EDTA4-,
Fe(III)EDTA and cannot accommodate two such molecules to give comretition from ML2. However, eventhoughthehexadentateEDTA ken from a figure may occupy all of the coordination sites, another,
lowerdentate ligand can displace one ormore ofthe
coordinating carboxyl groups. With Cr(III), the
Further, many EDTA chelate is quinquedentate with acoordinated
xist as such at H20 in the sixth position (18). The coordinated H20
mply dissolved is labilized by the free carboxylate of EDTA and
)mate, CrO42-, easily replaced by acetate or azide to form the
y ofCr2O72- as mixed complexCr(EDTA)Xn+1). Thedisplacement
d immediately of ligand groups during mixed complex formation
of 30 min (5). can lead to important new properties not normnally
w conversions possible in the parent binary complex, e.g., forma-
3 may obtain tion of protonated species and ligand-ligand inter-
mnding on the actions within the coordination sphere (19).
On of the solu- When a second ligand, A, occupies uncoordinated
sites in a binary complex, an important correlation
ensues, namely that the stability of the mixed
xes ligand chelate is greater, the larger the difference between the log K1/K2 values [the Kfin Eq. (2)] of
sually combine the binary complexes (20).
nple, the bind- Statistically, a metal ion prefers or favors combi-
Lally occurring nation with different ligands rather than two ofthe
;ed from their same (21, 22). However, thestability ofsomemixed
urns out that complexes exceedthatexpected fromthe statistical
h a copper ion factor by many orders of magnitude.
ifferent amino It isinteresting to note that inbiological systems
ixedcomplexes the imidazole moiety of histidine enhances the
)d as described stability of mixed complexes when an -0- ligand
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FIGURE 2. Calculated distribution ofCu(II) and Zn(II) among 22 amino acids; Cu2+ = 2.7 X 10-7M and Zn2+ = 3.3 x 10-6 M. The
amino acid concentrations were those known to exist in blood plasma. SAA is a composite representing alanine + arginine +
isoleucine + leucine + valine. The bar graphs were constructed from data tabulated by Perrin and Agarwal (17). Altogether 19
copper species were estimated to exist, accounting for 98% ofthe total copper, while 20 zinc species accounted for 93% ofthe total
zinc. In the case of copper, about 86% of all the species were mixed ligand complexes, while about 40% of the zinc species were
mixed ligand complexes.
atom is involved (19). With synthetic chelants such
as nitrilotriacetic acid (NTA) and imidazole, transi-
tion metals form strong mixed complexes. In natu-
rally occurring mixed complexes with proteins, the
imidazole moeity from histidine together with -0-
donor atoms is ubiquitous (e.g., hemoproteins and
the non-heme hemocyanins).
Oxidation-Reduction
Chelation serves to stabilize that oxidation state
of a metal ion forming the most stable chelate with
the particular chelant. For example, an unusual
oxidation state ofAg2+ can be stabilized by chela-
tionwith2,2'-dipyridylandthatofNi3 + bychelation
with o-phenylenedimethylarsine (11). The stability
of a metal complex to oxidation-reduction is a
function ofthe stability ofthe metalcomplex. These
are important considerations in biological systems
when it is desired to use or maintain a given
oxidation state.
Biological Consequences and
Applications
I have already alluded to several biological roles
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of chelation. In this section I will cite several
additional ones useful for biomedical purposes.
Lipophilicity and Intracellular
Transport
In the classical work of Albert on the anti-
microbial activity ofthe Fe(II) and Cu(II) chelates
of 8-hydroxyquinoline and their derivatives (23),
only the neutral 1:2 chelate was able to pass
through the cell membrane. Within the cell the 1:2
chelate dissociated into the 1:1 chelate which was
the actualantibacterial agent, presumablybyforming
aternarycomplexwithessential enzymes. Similarly,
with Fe(III), only the neutral 1:3 chelate could
penetrate the cell, where again dissociation took
place. It is possible, as Gershon and co-workers
have shown (24), to replace one of the 8-hydro-
xyquinolines in the 1:2 chelate of copper with
bidentate arylhydroxy acids such as salicylate. The
resulting mixed ligand complex is also neutral and
antibacterial. Thecobalt(II)-EDTAchelate can com-
bine with cyanide, and, in fact, the mixed complex
has been recommended and used as an antidote
cyanide poisoning (16).
As a means of enhancing intracellular penetra-
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the functional groupings, such as the carboxyls in
EDTA, have been accomplished on the assumption
that the active ligand groupings within the cell are
released by hydrolysis of the ester. In fact, such
compounds have been effective in removing heavy
metals such as Ce, Y, and Pu from the liver.
Unfortunately, these esterified compounds have a
low therapeutic index (14).
It is feasible to use metabolic inhibitors to jam
metabolic reactions such as the tricarboxylic acid
cycle. Forexample, Pbreacts with citrate toform a
moderately strong chelate but parenteral adminis-
tration of citrate has little effect because of the
rapid metabolism of the citrate. When sublethal
doses ofsodium fluoroacetate are given to rats, the
citrate levels increase 20-fold or more within the
spleen, kidney, and liver. In fact, fluoroacetate
administration caused a small but significant (15%)
decrease in the acute toxicity of Pb (25).
Catalase-like Activity
ThedecompositionofH202iscatalyzedbychelated
metal ions though the rate is not as efficient as the
iron-containing enzyme, catalase, in terms of the
number ofmolecules of H202 decomposed per unit
time. The mechanism of catalysis by synthetic
chelates, which is far greater than that due to the
uncomplexed metal ion, utilize the chelating prop-
erties ofperoxide which acts as a bidentate ligand,
HOO-, as described by Wang (26). Copper chelates
such as Cu - histamine and Cu - histidine are good
catalysts at pH 7. The mechanism involves again
the chelating property of HOO-. It was shown (27)
that two adjacent coordination sites of the Cu(II)
must be available. Hence, if the quadridentate
copper is chelated by a tridentate or tetradentate
chelant, no catalytic property is observed.
Viral Interactions
Metal chelates which contain vacant coordination
sites appear to combine with a sulfur bridge ofthe
protein coating of a virus. This, as proposed by
Eichhorn (28) changes cleavage, enabling the DNA
to leave the virus (15). Virus T2 bacteriophage
infect E. coli by a similar mechanism. The DNA
passes from the phage to the bacteria, an essential
step in viral replication. Cd(CN)2 appears to act by
the formation ofa bond between the metal complex
and a sulfur bridge of the protein coating of the
virus. With virus T2 bacteriophage it is believed
that a zinc complex in the cell wall ofthe bacterium
exists and is bound to a sulfur-containing bond of
the protein coating which is then destroyed. Note
that these proposed mechanisms involve ternary
complex formation.
Miscellaneous
Complexes and chelates ofplatinum(II) are prov-
ing to be effective anticancer agents. The cis-
dichlorodiammineplatinum, a mixed complex, is
finding widespread clinical applications as described
by Rosenberg (29) in a significant review. Other
active complexes ofPt include those in which one of
the ligands is bidentate, such as dichloroethyl-
enediammineplatinum. It is conceivable that these
Pt compounds interact with DNA via ternary
complex formation.
Mixed complex formation may be utilized also as
a ligand scavenger to transport ligands or hasten
their elimination, as mentioned earlier. This phe-
nomenon could, in principle, utilize nontoxic binary
chelates for the transport of chemotherapeutic
drugs to target sites, or to detoxify poisonous
substances including pesticides which possess func-
tional groupings capable of chelation or, which
acquire such groupings during metabolism. Of in-
terest is the role ofmetal and ligand scavenging in
the induction or reversal of mutagenic effects (5).
Metals and theircomplexed forms playimportant
roles in various diseases (30). For example, copper
and copper complexes have been postulated to play
a role in inflammatory processes (31). In a series of
papers, Williams and coworkers (32) have reviewed
and analyzed the role of metal complexes in rheu-
matoid arthritis, especially those ofternary copper
complexes.
It is tempting to conclude that the so-called role
ofmetals in carcinogenesis reflects the transport of
the binary and ternary complexes of the metals to
and from intracellular target sites.
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